Acadian Asset Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-753,140
Closed -$4.4M 2054
2022
Q4
$4.4M Buy
753,140
+123,841
+20% +$723K 0.02% 480
2022
Q3
$4.21M Sell
629,299
-214,026
-25% -$1.43M 0.02% 446
2022
Q2
$3.55M Buy
843,325
+49,219
+6% +$207K 0.02% 493
2022
Q1
$2.68M Buy
794,106
+11,293
+1% +$38K 0.01% 605
2021
Q4
$2.47M Buy
782,813
+82,473
+12% +$260K 0.01% 607
2021
Q3
$2.29M Buy
700,340
+87,629
+14% +$286K 0.01% 646
2021
Q2
$2.59M Buy
612,711
+79,138
+15% +$334K 0.01% 638
2021
Q1
$2.66M Buy
533,573
+430,297
+417% +$2.15M 0.01% 654
2020
Q4
$1.31M Sell
103,276
-8,909
-8% -$113K 0.01% 901
2020
Q3
$1.1M Sell
112,185
-47,143
-30% -$463K ﹤0.01% 871
2020
Q2
$1.59M Sell
159,328
-25,732
-14% -$256K 0.01% 805
2020
Q1
$1.64M Sell
185,060
-46,108
-20% -$408K 0.01% 658
2019
Q4
$2.13M Sell
231,168
-34,701
-13% -$320K 0.01% 668
2019
Q3
$1.57M Sell
265,869
-74,833
-22% -$440K 0.01% 756
2019
Q2
$4.09M Sell
340,702
-194,471
-36% -$2.33M 0.02% 440
2019
Q1
$6.46M Sell
535,173
-121,331
-18% -$1.46M 0.03% 386
2018
Q4
$8.24M Sell
656,504
-273,268
-29% -$3.43M 0.04% 300
2018
Q3
$13.8M Sell
929,772
-11,510
-1% -$171K 0.06% 250
2018
Q2
$15.8M Buy
941,282
+95,863
+11% +$1.61M 0.07% 242
2018
Q1
$19.4M Buy
845,419
+547,383
+184% +$12.5M 0.08% 198
2017
Q4
$7.71M Buy
+298,036
New +$7.71M 0.03% 309
2016
Q4
Sell
-65,484
Closed -$661K 1807
2016
Q3
$661K Sell
65,484
-209,654
-76% -$2.12M ﹤0.01% 761
2016
Q2
$3.09M Buy
275,138
+172,735
+169% +$1.94M 0.02% 454
2016
Q1
$1.4M Buy
102,403
+59,296
+138% +$810K 0.01% 593
2015
Q4
$818K Buy
43,107
+28,185
+189% +$535K ﹤0.01% 722
2015
Q3
$279K Buy
+14,922
New +$279K ﹤0.01% 853